Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-03-26 @ 8:40 AM
Study NCT ID:
NCT04036461
Status:
TERMINATED
Last Update Posted:
2024-08-30
First Post:
2019-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-25
First Submit QC Date:
None
Study First Post Date:
2019-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-28
Last Update Post Date:
2024-08-30
Last Update Post Date Type:
ACTUAL